IBI3016

· Innovent Biologics (Suzhou) Co. Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IBI3016, covering 2026-01-20 to 2026-01-20. Get the full timeline:

Most recent: Clinical Trial Update: A Dose Finding Study of IBI3016 in Mild to Moderate Hypertensive Patients [Phase 2]